# FDA Inspection 1001535 - Camellix, LLC - January 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/camellix-llc/d0689309-4f12-4e69-84ec-781684780c03
Source feed: FDA_Inspections

> FDA Inspection 1001535 for Camellix, LLC on January 17, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001535
- Company Name: Camellix, LLC
- Inspection Date: 2017-01-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1120923 - 2020-03-13](https://www.keypedia.com/records/fda_inspections/camellix-llc/ea17b786-d95a-4fd6-879e-7aadd9b1e7ab)
- [FDA Inspection 1120923 - 2020-03-13](https://www.keypedia.com/records/fda_inspections/camellix-llc/e9f70fc5-c340-410f-b1a7-3b77a6709e9f)
- [FDA Inspection 1001535 - 2017-01-17](https://www.keypedia.com/records/fda_inspections/camellix-llc/a8a65c9c-a44a-4f60-b594-1bf60768257b)
- [FDA Inspection 1001535 - 2017-01-17](https://www.keypedia.com/records/fda_inspections/camellix-llc/e1b7e423-bb54-4bac-9df9-c64b019a7012)

Company: https://www.keypedia.com/companies/camellix-llc/6a204b49-c056-49f9-bf43-67fe55125440

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c